miR-1915-3p通过向SOCS4来调节巨核细胞和红细胞分化
Xin Yuan1, Pengcong Liu1, Lei Xu1
1Stem Cell and Regenerative Medicine Lab, Beijing Institute of Radiation Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.
Thrombosis journal
|August 9, 2024
概括
微RNA miR-1915-3p通过向巨核细胞和红色素原生细胞 (MEPs) 的SOCS4来负面调节红色素形成并促进血栓形成. 这一发现澄清了血细胞发育至关重要的信号通路.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 巨核细胞和红色素原生细胞 (MEP) 血统偏差对于血液细胞的生产至关重要.
- 在MEP分化中出现的干扰会导致血小板和红细胞疾病.
- 控制MEP差异化的信号通路尚未完全理解.
研究的目的:
- 研究miR-1915-3p在巨核细胞和红细胞分化中的作用.
- 阐明miR-1915-3p在MEP中的功能背后的分子机制.
主要方法:
- 使用miRNA模仿和海绵改变了miR-1915-3p的表达.
- 通过siRNA和过度表达等离子体来改变SOCS4的表达.
- 使用流式细胞计量分析了细胞表面标记物.
- 通过mRNA分析,生物信息学分析和双露西法酶记者分析确认了miR-1915-3p的目标.
主要成果:
- miR-1915-3p的过度表达抑制了红细胞分化,而敲击则促进了它.
- SOCS4被确定为miR-1915-3p的直接目标.
- 操纵SOCS4模仿或逆转miR-1915-3p对红色素和巨核细胞分化的影响.
结论:
- miR-1915-3p作为红色形成的负调节剂和血栓形成的正调节剂.
- SOCS4是miR-1915-3p在MEP差异化中的功能的一个关键媒介.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


